UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
13G
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT
NO. __)
INTELLECT NEUROSCIENCES,
INC.
(Name
of Issuer)
COMMON STOCK, $0.001
PAR VALUE PER SHARE
(Title
of Class of Securities)
(CUSIP
Number)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)
*The
remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures
provided in a prior cover page.
The information
required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
(Continued
on following page(s)
Page 1 of
4 Pages
CUSIP
No. |
|
13G |
|
Page
2 of 4 Pages |
1. NAMES
OF REPORTING PERSON
S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Alpha
Capital Anstalt
2. CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ☐
(b) ☐
3. SEC USE
ONLY
4. CITIZENSHIP
OR PLACE OF ORGANIZATION
Liechtenstein
5. SOLE
VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 62,288,855 Common Stock
6. SHARED
VOTING POWER - None
7. SOLE
DISPOSITIVE POWER – 62,288,855 shares of Common Stock
8. SHARED
DISPOSITIVE POWER – None
9. AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -
62,288,855
shares of Common Stock
10. CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☒
The aggregate amount in Row 9 represents
the maximum amount of shares that Alpha Capital Anstalt can beneficially control under a contractually stipulated 9.99% ownership
restriction. The full conversion of Alpha Capital Anstalt’s securities would exceed this restriction.
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12. TYPE
OF REPORTING PERSON
CO
CUSIP
No. |
|
13G |
|
Page
3 of 4 Pages |
ITEM 1 (a) NAME OF ISSUER: Intellect Neurosciences, Inc.
ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
550 Sylvan Avenue, Suite 101, Englewood Cliffs,
NJ 07632
ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt
ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Pradafant 7, Furstentums 9490, Vaduz, Liechtenstein
ITEM 2 (c) CITIZENSHIP: Liechtenstein
ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock
ITEM 2 (e) CUSIP NUMBER:
ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B):
Not applicable
ITEM 4 OWNERSHIP
(a) AMOUNT BENEFICIALLY OWNED: 62,288,855 Shares
of Common Stock
(b) PERCENT OF CLASS: 9.99%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON
HAS:
(i) SOLE POWER TO VOTE OR DIRECT THE VOTE
62,288,855 Shares
(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE
0 Shares
(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE
DISPOSITION OF
62,288,855 Shares
(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE
DISPOSITION OF
0 Shares
CUSIP
No. |
|
13G |
|
Page
4 of 4 Pages |
ITEM 5 OWNERSHIP
OF FIVE PERCENT OR LESS OF A CLASS
Not
applicable
ITEM 6 OWNERSHIP
OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not
applicable
ITEM 7 IDENTIFICATION
AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not
applicable
ITEM 8 IDENTIFICATION
AND CLASSIFICATION OF MEMBERS OF A GROUP
Not
applicable
ITEM 9 NOTICE
OF DISSOLUTION OF GROUP
Not
applicable
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
February
5, 2015 |
|
(Date) |
|
|
|
/s/
Konrad Ackerman |
|
(Signature) |
|
|
|
Konrad
Ackerman, Director |
|
(Name/Title) |